Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GCTK
GCTK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GCTK News
Glucotrack Reports Reduced Net Loss in Q1 2026
May 15 2026
seekingalpha
Glucotrack Submits FDA Application to Advance Continuous Blood Glucose Monitoring Technology
May 14 2026
Newsfilter
Glucotrack Submits FDA Application to Advance Blood Glucose Monitoring Technology
May 07 2026
Newsfilter
GlucoTrack Reports Narrowed Net Loss for 2025 Fiscal Year
Mar 31 2026
NASDAQ.COM
Glucotrack Files IDE for Innovative CBGM Technology
Mar 30 2026
Newsfilter
Glucotrack Reports Q4 2025 Financial Results
Mar 30 2026
seekingalpha
GlucoTrack Seeks FDA Investigational Device Exemption for Glucose Monitoring
Mar 28 2026
Yahoo Finance
Glucotrack Shares Surge 15% on Upcoming FDA IDE Filing
Mar 27 2026
stocktwits
Glucotrack Advances FDA Submission for Continuous Glucose Monitoring Technology
Mar 27 2026
Newsfilter
Glucotrack Secures Three New Patents for CBGM Technology
Jan 29 2026
stocktwits
Glucotrack Secures $4 Million from Institutional Investor in Stock Purchase Agreement
Dec 30 2025
Newsfilter
Major Stocks Including New Mountain Finance, Texas Instruments, and Analog Devices Decline in Monday's Pre-Market Trading
Sep 15 2025
Benzinga
Check-Cap Shares Surge 183%; Discover 20 Stocks Making Moves in Premarket Trading
Sep 15 2025
Benzinga
Dow Drops 200 Points as US Consumer Sentiment Declines in September
Sep 12 2025
Benzinga
US Stocks Show Varied Performance; Adobe Reports Positive Q3 Earnings
Sep 12 2025
Benzinga
Reasons Behind GlucoTrack (GCTK) Stock Surging More Than 100% Today and Future Outlook
Sep 12 2025
TipRanks
Show More News
